Mouse Anti-Human Ubiquilin Monoclonal Antibody,, Clone 3B8A10 from Invitrogen

ID clarifier: platform...

The PROTEAN II xi multi-cell 2-D conversion kit converts the PROTEAN II xi multi-cell to the PROTEAN II XL multi-cell for a wider format cell that accepts 17 to 18 cm IPG strips....

The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....

... XL cell, wide format, is used for vertical electrophoresis ... gels and requires 1.2 L of running buffer. It ... 2.0 mm IPG conversion kit, which contains accessories for ... sets of IPG clamps, 2 sets of 20 x ...

Biology Products:

Rocking table Kick II from Sigma-Aldrich PROTEAN II xi Multi-Cell 2-D Conversion Kit from Bio-Rad SVT3-2 Diverter Valve from Bio-Rad PROTEAN II XL Cell, wide format, 2.0 mm from Bio-Rad

(Date:12/17/2009)... have discovered evidence that suggests a genetic variant may ... with asthma and adults who smoke, according to a ... Blood Institute (NHLBI), which is part of the National ... association between the genetic variant and a lowered risk ... who smoke. COPD is a lung disease most ...

(Date:12/17/2009)... accumulate excessive errors in the proteins they produce, ... cell suicide programme; however, beforehand the cells attempt ... rescue responses. Scientists know only the general outline ... interactions between them and the molecular components involved. ... (IRB Barcelona) have designed a new tool to ...

(Date:12/16/2009)... undergo a personality change in warmer water, according to ... make some species more aggressive. , Experiments with two ... have shown for the first time that some reef ... that these individual differences are even more marked as ... one or two degrees may have only a small ...

Breaking Biology News(10 mins):Media availability: Genetic variant may control lung function and risk of COPD 2 Researchers design a tool to induce controlled suicide in human cells 2 Researchers design a tool to induce controlled suicide in human cells 3 Fish with attitude: Some like it hot 2 Drunk Drivers May Respond to Brief Motivational Interview 62200 1 Drunk Drivers May Respond to Brief Motivational Interview 62200 2 Seniors May Need Help Overcoming Holiday Blues 62198 1 Seniors May Need Help Overcoming Holiday Blues 62198 2 FDA Approves Agriflu Seasonal Influenza Vaccine 6556 1 FDA Approves Agriflu Seasonal Influenza Vaccine 6556 2

[0] Media availability: Genetic variant may control lung function and risk of COPD [0] Researchers design a tool to induce controlled suicide in human cells [0] Fish with attitude: Some like it hot

... When it comes to picking a mate, Crosby, Stills, Nash ... the one you love, love the one youre with. As ... the animal kingdom, too. , New research that crosses ... (to them) mates, females and males apparently have ways to ...

... to atherosclerosis a condition that greatly increases the risk ... of a key protein that protects the heart and blood ... have found. , Their findings could lead to new ... cause of death in the United States as well ...

... than 50 years ago as a way to improve ... Tennessee researcher to a significant finding about how animal ... , In the middle of the 20th century, local ... a new species of salamander to California water bodies. ...

Other Biology News:Species still have more viable offspring if they can choose their best mate 2 Research explains link between cholesterol and heart disease 2 UT researcher sheds new light on hybrid animals 2 UT researcher sheds new light on hybrid animals 3

Species still have more viable offspring if they can choose their best mate Research explains link between cholesterol and heart disease UT researcher sheds new light on hybrid animals

(Date:12/16/2009)... 16 Decision Resources, one of the ... and healthcare issues, finds that, according to responses ... Abbott,s briakinumab (both interleukin inhibitors) will capture 22 ... the drug market for moderate to severe psoriasis. ... uptake, capturing nearly three times as much patient ...

(Date:12/16/2009)... Assessment with the Food and Drug Administration ... AEterna Zentaris Inc. (NASDAQ: AEZS ; ... company focused on oncology and endocrine therapy, ... Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of ... perifosine (KRX-0401), the Company,s PI3K/Akt pathway inhibitor, ...

(Date:12/16/2009)... HSP A has been found to be effectinve in improving ... ... 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the ... previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high quality ... yields. HSP-A has been found to be especially effective in ...

(Date:12/15/2009)... BioEnergy Institute (JBEI), one of three Department of Energy ... time-stamping service to protect its valuable intellectual property. ... ... (PRWEB) December 15, 2009 -- Surety, LLC , ... , today announced that the Joint BioEnergy Institute (JBEI), ...

Breaking Biology Technology:In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2 In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3 AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2 AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3 AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4 AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5 Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2 Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3 Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4 Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5

[0] In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market [0] AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma [0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property